Results 11 to 20 of about 1,229,168 (350)

Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis.

New England Journal of Medicine, 2019
BACKGROUND Results of an earlier analysis of a trial of the M72/AS01E candidate vaccine against Mycobacterium tuberculosis showed that in infected adults, the vaccine provided 54.0% protection against active pulmonary tuberculosis disease, without ...
D. Tait, M. Hatherill, Olivier Van Der Meeren, A. Ginsberg, Elana van Brakel, B. Salaun, T. Scriba, E. J. Akité, H. Ayles, A. Bollaerts, M. Demoitié, A. Diacon, T. Evans, P. Gillard, Elizabeth Hellström, J. Innes, Maria Lempicki, M. Malahleha, N. Martinson, Doris Mesia Vela, M. Muyoyeta, V. Nduba, Thierry G Pascal, M. Tameris, F. Thienemann, R. Wilkinson, F. Roman   +26 more
semanticscholar   +1 more source

Dynamical models of tuberculosis and their applications.

Mathematical biosciences and engineering : MBE, 2004
The reemergence of tuberculosis (TB) from the 1980s to the early 1990s instigated extensive researches on the mechanisms behind the transmission dynamics of TB epidemics.
C. Castillo-Chavez, B. Song
semanticscholar   +1 more source

MYCOBACTERIOSIS IN THE PRACTICE OF PULMONOLOGISTS AND PHTHISIOLOGISTS

Туберкулез и болезни лёгких, 2016
Goal of the study: to investigate the frequency of mycobacteriosis in the practice of pulmonologists and phthisiologists.Materials and methods. The analysis included medical files of 156 patients with various non-specific respiratory diseases and ...
A. E. Ergeshov, E. I. Shmelev, M. N. Kovalevskaya, N. L. Karpina, E. E. Larionova, L. N. Chernousova   +5 more
doaj   +1 more source

A CLINICAL CASE OF DISSEMINATED PULMONARY LESIONS WITH A CONCURRENT CONDITION

Туберкулез и болезни лёгких, 2018
The article presents a clinical case of a complex differential diagnostics of disseminated pulmonary lesions with a concurrent condition.
Anzhela S. Polyakova, Tatevik R. Bagdasaryan, Igor E. Stepanyan, Yury S. Berezovskiy, Vladimir V. Romanov, Atadzhan E. Ergeshov   +5 more
doaj   +1 more source

Tuberculosis [PDF]

Annual Review of Public Health, 2002
▪ Abstract  Tuberculosis is an infectious disease caused by bacteria in the Mycobacterium tuberculosis complex. Of these, the most common species to infect humans is M. tuberculosis. The TB bacillus is an extremely successful human pathogen, infecting two billion persons worldwide; an estimated 2 to 3 million people die from tuberculosis each year.
Parvathi, Tiruviluamala, Lee B, Reichman
openaire   +2 more sources

SEQUENCING OF SIX GENOMES OF CLINICAL STRAINS OF NON-TUBERCULOUS MYCOBACTERIA

Туберкулез и болезни лёгких, 2019
.
V. V. Ustinova, T. G. Smirnova, S. N. Аndreevskaya, I. Yu. Аndrievskaya, E. E. Larionova, L. N. Chernousova   +5 more
doaj   +1 more source

Acceptability, feasibility, and likelihood of stakeholders implementing the novel BPaL regimen to treat extensively drug-resistant tuberculosis patients

BMC Public Health, 2021
Background BPaL, a 6 month oral regimen composed of bedaquiline, pretomanid, and linezolid for treating extensively drug-resistant tuberculosis (XDR-TB) is a potential alternative for at least 20 months of individualized treatment regimens (ITR). The ITR
S. E. J. van de Berg, P. T. Pelzer, A. J. van der Land, E. Abdrakhmanova, A. Muhammad Ozi, M. Arias, S. Cook-Scalise, G. Dravniece, A. Gebhard, S. Juneja, R. Handayani, D. Kappel, M. Kimerling, I. Koppelaar, S. Malhotra, B. Myrzaliev, B. Nsa, J. Sugiharto, N. Engel, C. Mulder, S. van den Hof   +20 more
doaj   +1 more source

The New Xpert MTB/RIF Ultra: Improving Detection of Mycobacterium tuberculosis and Resistance to Rifampin in an Assay Suitable for Point-of-Care Testing

mBio, 2017
The Xpert MTB/RIF assay (Xpert) is a rapid test for tuberculosis (TB) and rifampin resistance (RIF-R) suitable for point-of-care testing. However, it has decreased sensitivity in smear-negative sputum, and false identification of RIF-R occasionally ...
S. Chakravorty, A. Simmons, M. Rowneki, Heta Parmar, Yuan Cao, J. Ryan, P. Banada, Srinidhi Deshpande, S. Shenai, A. Gall, J. Glass, Barry Krieswirth, S. Schumacher, P. Nabeta, N. Tukvadze, C. Rodrigues, A. Skrahina, E. Tagliani, D. Cirillo, A. Davidow, C. Denkinger, D. Persing, R. Kwiatkowski, Martin Jones, D. Alland   +24 more
semanticscholar   +1 more source

Prevention of Infection with Mycobacterium tuberculosis by H4:IC31® Vaccination or BCG Revaccination in Adolescents

New England Journal of Medicine, 2018
BACKGROUND Recent Mycobacterium tuberculosis infection confers a predisposition to the development of tuberculosis disease, the leading killer among global infectious diseases.
E. Nemes, H. Geldenhuys, V. Rozot, Kathryn Tucker Rutkowski, Frances Ratangee, N. Bilek, Simbarashe Mabwe, Lebohang Makhethe, Mzwandile Erasmus, Asma Toefy, H. Mulenga, W. Hanekom, S. Self, L. Bekker, R. Ryall, S. Gurunathan, C. Diazgranados, P. Andersen, Ingrid Kromann, Thomas Evans, R. Ellis, Bernard S Landry, D. Hokey, R. Hopkins, A. Ginsberg, T. Scriba, M. Hatherill   +26 more
semanticscholar   +1 more source

FUNCTIONAL RESPONSE TO ENDOBRONCHIAL VALVE IMPLANTING TO THOSE SUFFERING FROM PULMONARY DESTRUCTIVE TUBERCULOSIS

Туберкулез и болезни лёгких, 2016
Goal of the study: to investigate the changes in ventilation and gas exchange function of the lungs before and after 1-1.5 months after installation of endobronchial valve (EV) aimed at cavity healing in pulmonary destructive tuberculosis patients ...
L. A. Popova, E. A. Shergina, O. V. Lovacheva, T. R. Bagdasaryan, N. A. Chernykh, V. B. Nefedov   +5 more
doaj   +1 more source